based on 13 analysts
84.62%
Buy
15.38%
Hold
0.00%
Sell
Based on 13 analysts offering long term price targets for Krishna Institute of Medical Sciences Ltd. An average target of ₹576.54
Source: S&P Global Market Intelligence
Krishna Institute of Medical Sciences Ltd price forecast by 13 analysts
Upside of1.65%
High
₹675
Target
₹576.54
Low
₹406.4
Krishna Institute of Medical Sciences Ltd target price ₹576.54, a slight upside of 1.65% compared to current price of ₹584. According to 13 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Krishna Institute of Medical Sciences Ltd revenue growth forecast
Expected growth rate Q1, FY2026:52.06%
Forecast
Actual
Including amortisation and stock based compensations
Krishna Institute of Medical Sciences Ltd EPS growth forecast
EPS estimate Q1, FY2026:46.45%
Forecast
Actual
Source: S&P Global Market Intelligence
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 4.1 % |
3 Month Return | + 16.5 % |
1 Year Return | + 46.52 % |
Market Stats | |
Previous Close | ₹567.20 |
Open | ₹563.95 |
Volume | 9.78L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹22,695.88Cr |
P/E Ratio | 68.54 |
PEG Ratio | -251.97 |
Market Cap | ₹22,695.88 Cr |
P/B Ratio | 8.82 |
EPS | 8.398 |
Dividend Yield | 0 |
Sector | Healthcare |
ROE | 13.46 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
BUY | ₹22,695.88 Cr | 36.89% | 0.58 | ₹336 Cr | ₹2,498 Cr | |
BUY | ₹25,790.33 Cr | 64.12% | 0.69 | ₹789 Cr | ₹5,018 Cr | |
BUY | ₹96,999.34 Cr | 158.58% | 0.53 | ₹1,057 Cr | ₹5,704 Cr | |
BUY | ₹49,661.15 Cr | 73.9% | 0.54 | ₹645 Cr | ₹7,175 Cr | |
BUY | ₹96,147.36 Cr | 71.89% | 0.65 | ₹917 Cr | ₹19,059 Cr |
Organisation | Krishna Institute of Medical Sciences Ltd |
Headquarters | Secunderabad |
Industry | Healthcare |
E-voting on shares | Click here to vote |
Key events for Krishna Institute of Medical Sciences Ltd
Krishna Institute of Medical Sciences (KIMS) shows robust EBITDA growth of 27% YoY, prompting a revised target price of Rs 675/share. New leadership and clinical talent hiring across regions are expected to enhance profitability and revenue. The management anticipates a 22% EBITDA CAGR over FY24-27E, with a focus on achieving faster breakeven in new clusters. However, delays in breakeven remain a key risk.
KIMS Reports Strong Q2 Results, Stock Volatile - 11 Nov, 2024
Krishna Institute of Medical Sciences (KIMS) reported strong Q2 FY25 results, with significant increases in revenue and net profit. The stock initially surged but ended lower, reflecting market volatility despite positive financial performance.
KIMS Hospitals Expands Operations in Kerala - 07 Nov, 2024
Krishna Institute of Medical Sciences (KIMS) Hospitals plans to expand into Kerala, establishing 3,000 beds and creating 10,000 jobs over the next five years.
KIMS Hospitals Expands Operations in Kerala - 06 Nov, 2024
KIMS Hospitals is expanding into Kerala, planning to establish 3,000 new beds over five years. The company has begun operations by acquiring Sreechand Hospital and entering an O&M contract with Westfort Hospital. Future plans include developing health cities and specialized centers in various districts.
KIMS Reports Strong Q1 Performance and Strategic Acquisitions - 19 Oct, 2024
Krishna Institute of Medical Sciences (KIMS) shows robust Q1FY25 performance with a 12.9% YoY net income growth. Recent acquisitions and partnerships enhance market position.
KIMS Hospitals Secures ₹700 Crore Tech Deal - 18 Oct, 2024
Krishna Institute of Medical Sciences has entered a ₹700 crore agreement with Wipro GE Healthcare for medical technology procurement, covering existing and upcoming facilities over three years.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
Retail Investor have increased holdings from 11.22% to 13.03% in Sep 2024 quarter
MF Holding Up
Mutual Funds have increased holdings from 25.30% to 25.77% in Sep 2024 quarter
Price Rise
In the last 3 months, KIMS stock has moved up by 16.5%
Revenue Rich
Revenue is up for the last 4 quarters, 609.09 Cr → 782.3 Cr (in ₹), with an average increase of 8.0% per quarter
Profit Spike
Netprofit is up for the last 3 quarters, 65.5 Cr → 107.4 Cr (in ₹), with an average increase of 21.9% per quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 38.82% of holdings in Sep 2024 quarter
FII Holding Down
Foreign Institutions have decreased holdings from 17.84% to 15.85% in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 38.82% | 0.00 | |
Foreign Institutions | 15.85% | ||
Mutual Funds | 25.77% | 1.86 | |
Retail Investors | 13.03% | 16.12 | |
Others | 6.53% |
Krishna Institute of Medical Sciences Ltd in the last 5 years
Lowest (6.82x)
June 30, 2021
Today (68.54x)
November 19, 2024
Industry (96.41x)
November 19, 2024
Highest (72.73x)
September 16, 2024
Krishna Institute of Medical Sciences Ltd’s net profit jumped 16.71% since last year same period to ₹107.40Cr in the Q2 2024-2025. On a quarterly growth basis, Krishna Institute of Medical Sciences Ltd has generated 24.02% jump in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Krishna Institute of Medical Sciences Ltd is currently in a Bullish trading position according to technical analysis indicators.
Krishna Institute of Medical Sciences Ltd (KIMS) share price today is ₹584
Krishna Institute of Medical Sciences Ltd is listed on NSE
Krishna Institute of Medical Sciences Ltd is listed on BSE
PE Ratio of Krishna Institute of Medical Sciences Ltd is 68.54
PE ratio = Krishna Institute of Medical Sciences Ltd Market price per share / Krishna Institute of Medical Sciences Ltd Earnings per share
Today’s traded volume of Krishna Institute of Medical Sciences Ltd(KIMS) is 9.78L.
Today’s market capitalisation of Krishna Institute of Medical Sciences Ltd(KIMS) is ₹22695.88Cr.
Krishna Institute of Medical Sciences Ltd(KIMS | Price |
---|---|
52 Week High | ₹603.45 |
52 Week Low | ₹350 |
Krishna Institute of Medical Sciences Ltd(KIMS) share price is ₹584. It is down -3.22% from its 52 Week High price of ₹603.45
Krishna Institute of Medical Sciences Ltd(KIMS) share price is ₹584. It is up 66.86% from its 52 Week Low price of ₹350
Krishna Institute of Medical Sciences Ltd(KIMS | Returns |
---|---|
1 Day Returns | 16.8% |
1 Month Returns | 4.1% |
3 Month Returns | 16.5% |
1 Year Returns | 46.52% |